Servicios Personalizados
Revista
Articulo
Artículo en XML
Referencias del artículo
Traducción automática
Enviar artículo por emailIndicadores
Citado por SciELO 
Accesos
Links relacionados
Similares en
SciELO
Compartir
Permalink
Revista de investigación clínica
versión On-line ISSN 2564-8896versión impresa ISSN 0034-8376
Resumen
JUAREZ-VAQUERA, Víctor H.; ROSETTI-SCIUTTO, Marcos F.; MORALES-RUIZ, Valeria y ADALID-PERALTA, Laura V.. Meta-analysis to Implement Alpha-Synuclein in Extracellular Vesicles as a Potential Biomarker for Parkinson's Disease. Rev. invest. clín. [online]. 2023, vol.75, n.4, pp.193-202. Epub 18-Sep-2023. ISSN 2564-8896. https://doi.org/10.24875/ric.23000017.
Background:
In Parkinson's disease (PD), exosomes carry α-synuclein (α-syn), a fibrillar protein aggregates with potential value as a biomarker.
Objective:
Evidence on blood levels of exosomal α-syn in PD patients and controls was reviewed for their consistency.
Methods:
Thirty-six studies on exosomal α-syn concentrations in PD were identified in a systematic literature search and meta-analysis.
Results:
Both raw and ratio-adjusted blood exosomal α-syn levels were consistently higher in PD patients than in controls. The standardized mean difference (SMD) was 1.54 (0.18-2.90, CI95%, p < 0.01) and 1.53 (0.23-2.83, CI95%, p < 0.01), respectively.
Conclusion:
Our results suggest that exosomal α-syn concentrations could be a useful biomarker for PD.
Palabras llave : Parkinson; Alpha-synuclein; Exosome; Biomarker; Blood.
